Endocrinology, Vol 136, 3767-3773, Copyright © 1995 by Endocrine Society

ARTICLES

Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells

P Parini, B Angelin, PE Lobie, G Norstedt and M Rudling
Department of Medicine, Karolinska Institute, Huddinge University Hospital, Sweden.

Human GH (hGH) has been shown to stimulate hepatic low density lipoprotein (LDL) receptor expression in man in vivo. To further characterize this effect in vitro, we determined the expression of LDL receptors in cultured human hepatoma (HepG2) cells exposed to hGH. After incubation with hGH, stimulation of LDL receptors appeared at a concentration of 0.25 nM hGH. The presence of hGH receptors on HepG2 cells could be demonstrated by immunocytochemistry using a hGH receptor- specific monoclonal antibody. Binding studies, using 125I-labeled hGH, revealed high affinity binding with the appropriate somatogenic specificity. The LDL receptor induction was specific for hGH, as both bovine GH and recombinant human PRL were without effect. The LDL receptor stimulation occurred in parallel with increased levels of LDL receptor messenger RNA. Inclusion of dexamethasone and thyroid hormone in the incubation medium enhanced the LDL receptor stimulation by hGH. Although incubation with insulin-like growth factor-I (IGF-I) stimulated LDL receptor expression, the hGH-induced stimulation was unaltered after preincubation of cells with a monoclonal mouse anti-IGF- I antibody, suggesting that the release of IGF-I is not involved in LDL receptor stimulation by hGH. We conclude that hGH specifically induces the LDL receptor in cultured HepG2 cells at both the protein and the messenger RNA level, and that the induction is independent of IGF-I release.

This article has been cited by other articles:

				E. R Christ, M. H Cummings, M. Stolinski, N. Jackson, P. J Lumb, A. S Wierzbicki, P. H Sonksen, D. L Russell-Jones, and A M. Umpleby Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study. Eur. J. Endocrinol., March 1, 2006; 154(3): 459 - 466. [Abstract] [Full Text] [PDF]

				M. Matasconi, B. Angelin, and M. Rudling Pituitary control of lipoprotein and bile acid metabolism in male rats: growth hormone effects are not mediated by prolactin Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E114 - E119. [Abstract] [Full Text] [PDF]

				E. R. Christ, M. H. Cummings, N. Jackson, M. Stolinski, P. J. Lumb, A. S. Wierzbicki, P. H. Sonksen, D. L. Russell-Jones, and A. M. Umpleby Effects of Growth Hormone (GH) Replacement Therapy on Low-Density Lipoprotein Apolipoprotein B100 Kinetics in Adult Patients with GH Deficiency: A Stable Isotope Study J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1801 - 1807. [Abstract] [Full Text] [PDF]

				S. Lind, M. Rudling, S. Ericsson, H. Olivecrona, M. Eriksson, B. Borgstrom, G. Eggertsen, L. Berglund, and B. Angelin Growth Hormone Induces Low-Density Lipoprotein Clearance but not Bile Acid Synthesis in Humans Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 349 - 356. [Abstract] [Full Text]

				J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly Endocr. Rev., October 1, 2002; 23(5): 623 - 646. [Abstract] [Full Text] [PDF]

				D. Linden, A. Sjoberg, L. Asp, L. Carlsson, and J. Oscarsson Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytes Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1335 - E1346. [Abstract] [Full Text] [PDF]

				K. K. Kaulsay, H. C. Mertani, K.-O. Lee, and P. E. Lobie Autocrine Human Growth Hormone Enhancement of Human Mammary Carcinoma Cell Spreading Is Jak2 Dependent Endocrinology, April 1, 2000; 141(4): 1571 - 1584. [Abstract] [Full Text] [PDF]

				P. Parini, B. Angelin, and M. Rudling Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 832 - 839. [Abstract] [Full Text] [PDF]

				K.-C. Leung and K. K. Y. Ho Stimulation of Mitochondrial Fatty Acid Oxidation by Growth Hormone in Human Fibroblasts J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4208 - 4213. [Abstract] [Full Text] [PDF]

				B. Wyse and C. Sernia Growth Hormone Regulates AT-1a Angiotensin Receptors in Astrocytes Endocrinology, October 1, 1997; 138(10): 4176 - 4180. [Abstract] [Full Text] [PDF]

				P. Parini, B. Angelin, and M. Rudling Importance of Estrogen Receptors in Hepatic LDL Receptor Regulation Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1800 - 1805. [Abstract] [Full Text]

				W. Liao, B. Angelin, and M. Rudling Lipoprotein Metabolism in the Fat Zucker Rat: Reduced Basal Expression but Normal Regulation of Hepatic Low Density Lipoprotein Receptors Endocrinology, August 1, 1997; 138(8): 3276 - 3282. [Abstract] [Full Text] [PDF]

				W. Liao, M. Rudling, and B. Angelin Novel Effects of Histamine on Lipoprotein Metabolism: Suppression of Hepatic Low Density Lipoprotein Receptor Expression and Reduction of Plasma High Density Lipoprotein Cholesterol in the Rat Endocrinology, May 1, 1997; 138(5): 1863 - 1870. [Abstract] [Full Text] [PDF]

				W. Liao, M. Rudling, and B. Angelin Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor I on the Biological Activities of Endotoxin in the Rat Endocrinology, January 1, 1997; 138(1): 289 - 295. [Abstract] [Full Text] [PDF]